Panos Kokkinidis
Associate
Brussels
panagiotis.kokkinidis@lw.com
+32.2.788.6312
PRACTICES
- Antitrust & Competition
- Litigation & Trial
INDUSTRIES
- Aerospace, Defense & Government Services
- Healthcare & Life Sciences
- Hospitality, Gaming & Leisure
EDUCATION
- LL.M., University of Pennsylvania Law School, 2022
- LL.B., Aristotle University of Thessaloniki, 2018
LANGUAGES SPOKEN
- English
- German
- Greek
PROFILE
Panos Kokkinidis is an associate in the Brussels office of Latham & Watkins and a member of the firm’s Global Antitrust & Competition Practice.
Panos advises clients on a wide range of EU competition law and regulatory issues, with a particular focus on merger control and foreign direct investment (FDI) control.
His experience covers several industry sectors including aviation, manufacturing, medical devices, and pharmaceuticals.
Prior to joining Latham, Panos worked as a trainee at the Directorate General for Competition of the European Commission, where he focused on merger control issues in the transport sector.
EXPERIENCE
A selection of Panos’ experience includes advising:
- Cadence Design Systems, Inc. on merger control and FDI aspects of its US$1.24 billion acquisition of BETA CAE, an engineering simulation software business
- CyberArk on merger control aspects of its US$1.54 billion acquisition of Venafi, a leader in machine identity management
- Innovid, an independent connected TV (CTV) advertising delivery and measurement platform, on merger control aspects of its sale to Mediaocean
- Abcam, a biotech company, on FDI and merger control aspects of its US$5.7 billion sale to Danaher
- Bain Capital in its acquisition of F.I.S. Fabbrica Italiana Sintetici, a manufacturer of chemical products for the pharmaceutical industry
- Syneos Health, a biopharmaceutical solutions company, on merger control and FDI aspects of its US$7.1 billion sale to a consortium of private investment firm affiliates
- One Rock Capital Partners in its acquisition of Constantia Flexibles, a global packaging manufacturer
- ProMach, a packaging machinery company, on merger control and FDI aspects of its sale to funds managed by BDT Capital Partners
- A leading manufacturer of medical devices on behavioral aspects of its business activities